Log In
BCIQ
Print this Print this
 

HTX-019

  Manage Alerts
Collapse Summary General Information
Company Heron Therapeutics Inc.
DescriptionIV, polysorbate 80-free formulation of aprepitant, an NK1 receptor antagonist
Molecular Target Neurokinin 1 (NK1) substance P receptor (TACR1)
Mechanism of ActionNeurokinin-1 (NK-1) (Substance P) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationEmesis
Indication DetailsPrevent chemotherapy induced nausea and vomiting (CINV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today